Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
about
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cellsWnt signaling pathway in non-small cell lung cancerE-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPasesGenetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patientsDown-regulation of the canonical Wnt β-catenin pathway in the airway epithelium of healthy smokers and smokers with COPD.Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.Epstein-Barr virus-encoded latent membrane protein 2A promotes the epithelial-mesenchymal transition in nasopharyngeal carcinoma via metastatic tumor antigen 1 and mechanistic target of rapamycin signaling induction.Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancerCanonical Wnt signaling activity in early stages of chick lung development.Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancerUbiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinomaThe role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells.Overexpression of hepatocyte nuclear factor 4α in human mesenchymal stem cells suppresses hepatocellular carcinoma development through Wnt/β-catenin signaling pathway downregulation.DNAJB6 governs a novel regulatory loop determining Wnt/β-catenin signalling activity.Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis.Docosahexaenoic acid inhibits 12-O-tetradecanoylphorbol-13- acetate-induced fascin-1-dependent breast cancer cell migration by suppressing the PKCδ- and Wnt-1/β-catenin-mediated pathwaysWnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target.FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.Role of Wnt canonical pathway in hematological malignancies.Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity.Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma.Promoter methylation of WNT inhibitory factor-1 and expression pattern of WNT/β-catenin pathway in human astrocytoma: pathologic and prognostic correlations.Activation of Wnt/β-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity.Matrix metalloproteinases: their functional role in lung cancer.MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.Musings on genome medicine: cancer genetics and the promise of effective treatment.Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients.EMX2 is epigenetically silenced and suppresses growth in human lung cancer.Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.Pro-opiomelanocortin gene delivery suppresses the growth of established Lewis lung carcinoma through a melanocortin-1 receptor-independent pathway.[The correlation between the expression of Wnt1 and prognosis in resected non-small cell lung cancer].Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations.
P2860
Q24318355-19EEEB5F-E92D-4523-9788-25D6EA2C0F0CQ26825936-F4A8A778-0ABB-4B03-A70C-B8BAEE9FF57EQ28385103-28B07B01-BAAF-4D2B-9376-9EF5F024842DQ33705233-D194C18E-CA86-4625-BD56-1417278D0E19Q33872263-AD76E2F3-5FDF-48F7-BDA4-4FA3C87380D6Q33902551-5B2FC296-D034-48EF-B4A9-5637FEC483CAQ34138056-D50B51AF-E6AE-4A95-8861-31335BF522F6Q34261571-527465CC-89B9-4210-B4EE-004FF7DC9DEDQ34694101-51CDB656-2A46-4FB7-92BD-6B1CD7F18022Q34795851-34851336-C625-47F0-8073-59066B021E1FQ35474144-6F9DC968-9CBE-429A-B6A8-098ACB4D4A7FQ35558027-ED508525-2A40-402D-8A9C-B90A20C6B564Q36536565-65DB03B4-5801-404A-8A30-1883A7F97397Q36587552-FBBECB4F-3DBC-4C47-A08B-513443FBF56CQ36589860-BF0B6411-54B0-492D-8496-10B88BA0C6F6Q36887069-06826218-EBC9-42FF-9003-33E6AA536741Q37013296-662A2162-0051-4425-BEAF-EFC117F2E21EQ37015877-52B672A3-FE6F-4D67-AE1E-536F74699623Q37227295-9C57AAF5-D43D-4CBB-8FDA-AA8043A8063FQ37295281-7CDDCB2C-F016-4A22-8D3C-72CF93EC7015Q37433642-6D856423-F13E-4D0C-B794-694829870771Q37565073-ACE72B5C-DC69-4194-9C9A-9970C058C778Q37789052-E5C5419D-CFB1-43F1-9A68-344756EAA69EQ37866602-6DC83B6C-9A58-46F6-9200-BC40E8C7407BQ38323055-BE445703-F166-42BF-9AC7-9957CDADB873Q38953360-28692788-44B0-41A1-972C-C042C9451536Q39208810-DCE033C8-2354-40CC-B638-9B12D5C7B03BQ39259388-90181126-BFCB-4CDD-8A16-CA97DB393D8EQ39388493-37082C8F-471C-47B7-A94B-D88B436E9D3AQ39406412-6E5A23ED-EFCF-4521-A6F6-AA740760A77FQ39783590-EBAB2204-0771-4D1E-BC41-90CE3CBE2E81Q39979970-60B53743-93F5-4CFF-BA80-C7E37C099924Q42073845-4723CECF-EED2-4C06-BE01-1A948879BC8CQ42729659-F0CF4B05-9B53-4630-B38A-7E57F0A7D80FQ42984756-20F96388-63B9-456A-98B2-62A01D67DFBCQ43578829-92756582-51BC-4CE1-A69C-8DECB633E53FQ45875634-F4D77637-9B34-4849-A790-0B9586473A03Q55425896-5511C77C-7ED4-41D9-AF6C-E1B95FDB96A2Q55463889-8D73A3EF-2C1B-4B0E-8DC5-B478B78699C5
P2860
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@ast
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@en
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@nl
type
label
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@ast
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@en
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@nl
prefLabel
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@ast
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@en
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@nl
P2093
P1476
Wnt1 overexpression promotes tumour progression in non-small cell lung cancer.
@en
P2093
Cheng-Long Huang
Hiroyasu Yokomise
Kyuichi Kadota
Masaki Ueno
Nariyasu Nakashima
Shinya Ishikawa
Takashi Nakashima
P304
P356
10.1016/J.EJCA.2008.08.004
P577
2008-09-13T00:00:00Z